Healthcare Tech

Ever since Amazon launched its digital pharmacy late last year, industry rivals have been worried the tech giant would steal the show. Rather than waiting to find out, they’re all scrambling to secure their spot on the stage. Some, like Nurx and Folx, are zeroing in on underserved or specific populations, hoping to build a

On Wednesday, federal officials quietly opened up access to VaccineFinder, a site that allows the U.S. public to search nationwide for approved Covid-19 vaccine providers. On vaccinefinder.org, users can enter an address or ZIP code and select a search area — say, within 10 miles — and get a list of providers with contact information,

Last January, Samuel Scarpino wasn’t sure what to make of Covid-19. The director of Northeastern University’s Emergent Epidemics Lab, he, along with every other epidemiologist in the world, was trying to interpret the earliest data on the new virus. He was soon pulled into working on a spreadsheet, started by a group of international epidemiologists,

In early May, a wing of Ohio State University’s Wexner Medical Center was eerily empty. The space had been cleared of patients as the pandemic raged. But it wasn’t going to waste. Inside, a group of nurse practitioners were playing a game of digital tag. Lauren Chrzanowski, who has type 1 diabetes, was wearing a

More than a year after facing widespread criticism over its patient data-sharing arrangement with hospital chain Ascension, Google on Tuesday unveiled new details and a name for a core product of the partnership. The tool — a kind of Google search for electronic medical records — is called Care Studio and will now be available

Everyone working from home this year has figured out their own ways to stay focused. For Chris Lunt, it’s a squat red sphere he keeps on his desk, painted to depict the furrowed brow of Bodhidharma, the founder of Zen Buddhism — a Daruma doll. “It’s a doll you buy when you take on a

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science

The pandemic grounded tens of thousands of pharmaceutical reps who usually roam the country urging doctors to prescribe certain drugs — a shift that has opened the door for tech companies, who are pitching digital platforms on the promise that oceans of data can make pharma marketing better. After in-person sales activity plummeted last March,

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science

Advances in the life sciences over the past decade have made it possible to manipulate genetic codes on the molecular level. Devices can see inside the human body with a level of precision that seemed unfathomable just a few years ago. And in a matter of months, researchers have created a multitude of vaccines for

Less than a year since Zocdoc reinvented itself as a telehealth platform in the face of the pandemic, the company is again profitable, and on Thursday announced $150 million in fresh financing to fuel its ambitions. The company is staking its future on the buzzy promise of hybrid care. Before the pandemic, Zocdoc’s scheduling platform

As the world charges to vaccinate the population against the coronavirus, gene therapy developers are locked in a counterintuitive race. Instead of training the immune system to recognize and combat a virus, they’re trying to do the opposite: designing viruses the body has never seen, and can’t fight back against. It’s OK, reallay: These are

The great hope of artificial intelligence in breast cancer is that it can distinguish harmless lesions from those likely to become malignant. By scanning millions of pixels, AI promises to help physicians find an answer for every patient far sooner, offering them freedom from anxiety or a better chance against a deadly disease. But the

A long-documented, under-the-radar disparity is garnering new attention as the Covid-19 pandemic stretches into another year: Some pulse oximeters, which measure oxygen levels and are critical to making decisions about patient care, aren’t as accurate in Black patients and other people of color. New research on the issue has drawn the attention of lawmakers and

A vanguard of virtual behavioral health startups are attracting investor interest. The latest: Equip, which provides online treatment for eating disorders, announced Wednesday it has raised a $13 million Series A round. The round was led by Optum Ventures. New investor .406 Ventures joined, as did F-Prime Capital, which led the company’s seed round. Total

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science

The Biden administration’s recent investment of $230 million to expedite rapid production of the Ellume home Covid-19 test represents an audacious step forward in mitigating the pandemic. Some experts have criticized it as a “waste of money” because this kit costs more than other alternatives and because of the timing of the investment. I believe

For many people, January is a time for new beginnings. But for many telehealth patients, January 2021 means being plunged back into 2019 as Congress prepares to walk back some of the pandemic-related coverage and payment flexibilities it instituted for 33 million seniors and people with disabilities. In December 2020, I joined telehealth CEOs and

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science

The genetics testing company 23andMe will enter the public markets via a special purpose acquisition corporation sponsored by Virgin Group founder Richard Branson, a deal that values the company at $3.5 billion. The transaction with VG Acquisition Corp. will provide a burst of capital to 23andMe as it seeks to expand its business beyond direct-to-consumer